Here's why the Creso Pharma (ASX:CPH) share price is storming 11% higher

The Creso Pharma Ltd (ASX:CPH) share price is storming higher on Monday after announcing its expansion into a new market…

| More on:
Investor happily looking at rising share price on laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Creso Pharma Ltd (ASX: CPH) share price has been a strong performer on Monday morning.

At one stage today, the cannabis company's shares were up as much as 11% to 25 cents.

The Creso Pharma share price has since pulled back a touch but remains 4.5% higher at 23.5 cents.

Why is the Creso Pharma share price racing higher?

Investors have been buying Creso Pharma shares after it announced its expansion into the Pakistan market.

According to the release, the company has signed a comprehensive distribution agreement with leading nutritional supplements company, Route2 Pharm.

The agreement will see Route2 Pharm import, market, distribute, and sell the company's hemp derived therapeutic products exclusively into Pakistan and The Philippines. Route2 Pharm will also have non-exclusive rights to other potential target markets including Cambodia, Afghanistan, Azerbaijan, Bangladesh, Georgia, the Maldives, Myanmar, Tajikistan, Turkmenistan, Uzbekistan, and Vietnam.

The release explains that Route2 Pharma is a subsidiary of Route2Health. It has over thirty years of pharmaceutical sciences experience and produces and distributes world-class herbal remedies and dietary supplements. Route2Health is based in Pakistan and has United States Pharmacopeia (USP) GMP compliant manufacturing facilities and global partnerships.

As part of the agreement, to retain its exclusivity rights in Pakistan and The Philippines, Route2 Pharm must make minimum order quantities worth approximately $2.5 million a year.

Creso Pharma's Non-Executive Chairman, Adam Blumenthal, commented: "This Agreement has the potential to take Creso into markets with a combined population of over 750 million people. Our mission is to deliver access to affordable, high quality, broad spectrum, GMP products for the betterment of people's lives everywhere. We're delighted to conclude this important partnership, through which we hope to provide the opportunity for millions of people to have access to our innovative products."

This latest gain means the Creso Pharma share price is now up 31% since the start of the year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A mature-aged woman wearing goggles and a red cape, rides her bike along the beach looking victorious.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a tough Tuesday for investors.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why BlueScope, DroneShield, Monadelphous, and SGH shares are racing higher today

These shares are outperforming on Tuesday. But why?

Read more »

Man looking at digital holograms of graphs, charts, and data.
Share Gainers

Top 5 ASX 200 tech shares for growth in 2025

It was a rollercoaster year for ASX 200 tech shares, with fears of an AI bubble sending them into a bear…

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX had a lukewarm start to the week today.

Read more »

A young woman raises her arm in celebration against a backdrop of brightly coloured fireworks in the sky.
Share Gainers

Buying ASX uranium shares like Paladin Energy? Here's why they're starting 2026 with a bang!

Investors are piling into ASX uranium stocks in these early days of 2026. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why Civmec, Fenix, Paladin Energy, and Vulcan Steel shares are pushing higher today

These shares are starting the week on a positive note.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why 4DMedical, Elsight, Judo, and Nickel Industries shares are pushing higher today

These shares are starting the year in a positive fashion. But why?

Read more »

Australian notes and coins mixed together.
Financial Shares

Top 5 ASX 200 financial shares of 2025

Despite CBA shares tumbling in the second half, the financial sector held up well in 2025.

Read more »